1-155610249-A-G
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PVS1_StrongPM2
The NM_018116.4(MSTO1):c.1A>G(p.Met1?) variant causes a start lost change. The variant was absent in control chromosomes in GnomAD project. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_018116.4 start_lost
Scores
Clinical Significance
Conservation
Publications
- mitochondrial diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndromeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Broad Center for Mendelian Genomics, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_018116.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MSTO1 | TSL:1 MANE Select | c.1A>G | p.Met1? | start_lost | Exon 1 of 14 | ENSP00000245564.3 | Q9BUK6-1 | ||
| MSTO1 | TSL:2 | c.1A>G | p.Met1? | start_lost | Exon 1 of 13 | ENSP00000357325.4 | Q9BUK6-7 | ||
| MSTO1 | TSL:1 | n.1A>G | non_coding_transcript_exon | Exon 1 of 13 | ENSP00000476353.1 | Q9BUK6-4 |
Frequencies
GnomAD3 genomes Cov.: 28
GnomAD4 exome Cov.: 6
GnomAD4 genome Cov.: 28
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.